FDA Clears Sacubitril/Valsartan for Children With Heart Failure FDA Clears Sacubitril/Valsartan for Children With Heart Failure
Sacubitril/valsartan is approved to treat symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients 1 year and older.FDA Approvals
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Alert Source Type: news